Natural Killer Cell Cancer Therapies Research Toolkit

Natural Killer Cell Cancer Therapies Research Toolkit

Regular price
$0.00
Sale price
$0.00
Regular price
Unavailable
Unit price
per 
Free Shipping

What Is It?

Immunotherapy is an incredibly promising cancer treatment method that retargets the immune system to kill cancer cells; it can eradicate both a tumor and its distant metastases as well as generate long term immunological memory to prevent relapse. Custom T cell immunotherapeutics are effective but relatively inaccessible as they are produced on a patient by patient basis and cost up to $500,000. An exciting alternative is natural killer (NK) cells, innate immune cells that can be given to patients from other donors and have inherent cancer cell-killing and antibody binding capabilities. Engineering NK cells can be difficult due to their heterogeneity and plasticity, but further research into their use as cell therapies - particularly in combination with clinical antibodies - could make a new class of powerful, inexpensive, off-the shelf immunotherapeutics that is accessible to a wider variety of cancer patients. 

This product contains three classes of genes: ligands, surface receptors, and transcription factors. Using these sets of free genes, researchers can manipulate NK cells, cancer cells, and “feeder” cells (used to trigger NK cells to proliferate up to a clinically relevant dose) to express a variety of surface and intracellular proteins. 

  1. The ligands contained within this FreeGenes product can be transduced or transfected into non-stimulatory feeder or cancer cells or NK cell lines to isolate their effects, or into stimulatory feeder cells to enhance their activating effects on NK cells. 
  2. The transcription factors can be transduced or transfected into NK cells to alter their behavior or phenotype.
  3. The activating or inhibitory receptors can similarly be transduced or transfected into NK cells to perturb their behavior. 

The combination of all of these ligands and receptors represents a powerful toolbox with which to intelligently and rationally design almost countless iterations of feeder cell - NK cell - tumor cell pipelines; they will enable both basic science and translational researchers to answer fundamental immunology questions about which molecules promote NK cell killing against which types of tumor cells in an unprecedented manner. They can also be used by synthetic biologists or bioengineers to design novel chimeric antigen receptors by combining intracellular and extracellular domains of different receptors to modify endogenous signaling pathways. All of these kinds of research will advance the goal of effective off-the-shelf cell therapies, which will drastically lower the cost of immunotherapy and make these life-saving treatments available to more patients. 

What Can It Be Used For?

The genes listed here can be expressed on NK cells, feeder cells, or tumor cells to study individual NK cell signaling pathways, strengths of activation of different receptor-ligand interactions, and whether certain NK cells are more or less resistant to inhibitory cues from cancer cells. These can all be combined in various combinations or used individually to assess synergistic effects as well. The CARs can be used to make NK cells that target surface molecules on B cells or any other cells, as long as an antibody or other targeting molecule can be designed against it.

Sample Workflow

  1. PCR amplify the gene of interest out of the supplied backbone
  2. Clone the gene into a mammalian expression vector of your choice
    1. Note that these genes do not come with a promoter sequence, so one must be present on your new backbone in order for the gene to be expressed
  3. Transfect or transduce NK cells, feeder cells, or tumor cells to express the corresponding protein
    1. Note that if you are transducing, you will need to produce virus - see here: https://www.addgene.org/protocols/lentivirus-production/
  4. Select the NK cells, feeder cells, or tumor cells that have successfully been transduced or transfected using a fluorescent molecule or selection agent such as blasticidin
    1. Note that the selection agents or fluorescent proteins are not included in the gene sequences, but the provided sequences all end with the beginning of the P2A self-cleaving peptide sequence so that a blasticidin resistance gene, GFP, or other gene can be incorporated into your vector without altering the function of the protein of interest - see here for more information about P2A: https://en.wikipedia.org/wiki/2A_self-cleaving_peptides and see here for information about blasticidin resistance: https://en.wikipedia.org/wiki/Blasticidin_S
  5. Test the expansion of NK cells after culture with modified feeder cells and compare to the unmodified feeder cells, or test the cytotoxic activity of engineered versus non-engineered NK cells against engineered or non-engineered tumor cells

Where Can I Find More Information?

https://en.wikipedia.org/wiki/Cancer_immunotherapy

https://en.wikipedia.org/wiki/Chimeric_antigen_receptor_T_cell

https://en.wikipedia.org/wiki/Natural_killer_cell

https://en.wikipedia.org/wiki/Antibody


 

Designed By: Nina Horowitz, Stanford University

Image Source

Genes

Gene Name NCBI ID Freegenes ID
IL15P1 Interleukin 15 Precursor 1 NP_000576.1 BBF10K_000502
IL15P2 Interleukin 15 Precursor 2 NP_751915.1 BBF10K_000503
IL2 Interleukin 2 NP_000577.2 BBF10K_000504
KIR2DL4IA killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4 isoform A NP_002246.5 BBF10K_000505
KIR2DL4IB killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4 isoform B NP_001074241.1 BBF10K_000506
KIR2DL4IC killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4 isoform C NP_001074239.1 BBF10K_000507
HLAG Homo sapiens major histocompatibility complex, class I, G (HLA-G), transcript variant 1 NP_001350496.1 BBF10K_000508
HLAG1 Homo sapiens major histocompatibility complex, class I, G (HLA-G), transcript variant 1 NP_001371219.1 BBF10K_000509
NKG2D KLRK1 killer cell lectin like receptor K1 NP_031386.2 BBF10K_000510
ULBP1I1 UL16 binding protein 1 isoform 1 NP_079494.1 BBF10K_000511
ULBP1I2 UL16 binding protein 1 isoform 2 NP_001304018.1 BBF10K_000512
ULBP2 UL16 binding protein 2 NP_079493.1 BBF10K_000513
CD28H TMIGD2 transmembrane and immunoglobulin domain containing 2 NP_653216.2 BBF10K_000514
B7H7 HHLA2 HERV–H LTR-associating protein 2 NP_009003.1 BBF10K_000515
CD40 cluster of differentiation 40 NP_001241.1 BBF10K_000516
CD40L CD154 cluster of differentiation 154 NP_000065.1 BBF10K_000517
TGFb transforming growth factor beta 1 NP_000651.3 BBF10K_000518
PDGF-DDtv1 platelet-derived growth factor D transcription variant 1 NP_079484.1 BBF10K_000519
PDGF-DDtv2 platelet-derived growth factor D transcription variant 2 NP_149126.1 BBF10K_000520
SDC2 HSPG syndecan 2 NP_002989.2 BBF10K_000521
2B4 Homo sapiens CD244 molecule NP_057466.1 BBF10K_000522
NKp44 NCR2 natural cytotoxicity triggering receptor 2 NP_004819.2 BBF10K_000523
StrepCAR-CD28z anti-streptavidin chimeric antigen receptor, intracellular CD28z N/A BBF10K_000524
StrepCAR-41BBz anti-streptavidin chimeric antigen receptor, intracellular 4-1BBz N/A BBF10K_000525
StrepCAR-2B4 anti-streptavidin chimeric antigen receptor, intracellular 2B4 N/A BBF10K_000526
CD19CAR-CD28z anti-CD19 chimeric antigen receptor, intracellular CD28z N/A BBF10K_000527
CD19CAR-2B4 anti-CD19 chimeric antigen receptor, intracellular 2B4 N/A BBF10K_000528
CD19CAR-41BBz anti-CD19 chimeric antigen receptor, intracellular 4-1BBz N/A BBF10K_000529
NR4A1 Nuclear Receptor Subfamily 4 Group A Member 1 NP_001189162.1 BBF10K_000530
NR4A2 Nuclear Receptor Subfamily 4 Group A Member 2 NP_006177.1 BBF10K_000531
CRTAM Cytotoxic and regulatory T cell molecule NP_062550.2 BBF10K_000532
CD96 TACTILE T cell activation, increased late expression NP_937839.1 BBF10K_000533
CLEC12A C-lectin type domain family 12 member A NP_612210.4 BBF10K_000534
CXCR6 c-x-c motif chemokine receptor 6 NP_006555.1 BBF10K_000535
RGS1 regulator of G protein signaling 1 NP_002913.3 BBF10K_000536
Hobit-i1 Homolog of Blimp-1 in T cells isoform 1 NP_001108231.1 BBF10K_000537
Hobit-i2 Homolog of Blimp-1 in T cells isoform 2 NP_001294854.1 BBF10K_000538
ID2 inhibitor of DNA binding 2 NP_002157.2 BBF10K_000539
GPR183 G-protein coupled receptor 183 NP_004942.1 BBF10K_000540
CD49a ITGA1 Integrin subunit alpha 1 NP_852478.1 BBF10K_000541
CD103 ITGAE integrin subunit alpha E NP_002199.3 BBF10K_000542

Bionet

The bionet enables open peer-peer exchange of functional biomaterials and associated data. This product may also be available from bionet nodes that are more convenient to you. Here are other bionet nodes who may be willing to provide you this specific product.

At the moment we are not aware of any other bionet nodes that provide this specific product.

x